235 related articles for article (PubMed ID: 21732673)
1. A single mutation in arrestin-2 prevents ERK1/2 activation by reducing c-Raf1 binding.
Coffa S; Breitman M; Spiller BW; Gurevich VV
Biochemistry; 2011 Aug; 50(32):6951-8. PubMed ID: 21732673
[TBL] [Abstract][Full Text] [Related]
2. The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation.
Coffa S; Breitman M; Hanson SM; Callaway K; Kook S; Dalby KN; Gurevich VV
PLoS One; 2011; 6(12):e28723. PubMed ID: 22174878
[TBL] [Abstract][Full Text] [Related]
3. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
4. Scaffolding mechanism of arrestin-2 in the cRaf/MEK1/ERK signaling cascade.
Qu C; Park JY; Yun MW; He QT; Yang F; Kim K; Ham D; Li RR; Iverson TM; Gurevich VV; Sun JP; Chung KY
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34507982
[TBL] [Abstract][Full Text] [Related]
5. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2.
Zhao M; Wimmer A; Trieu K; Discipio RG; Schraufstatter IU
J Biol Chem; 2004 Nov; 279(47):49259-67. PubMed ID: 15364949
[TBL] [Abstract][Full Text] [Related]
6. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
[TBL] [Abstract][Full Text] [Related]
7. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction at GPCRs: Allosteric activation of the ERK MAPK by β-arrestin.
Kahsai AW; Shah KS; Shim PJ; Lee MA; Shreiber BN; Schwalb AM; Zhang X; Kwon HY; Huang LY; Soderblom EJ; Ahn S; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2303794120. PubMed ID: 37844230
[TBL] [Abstract][Full Text] [Related]
9. Mutations of beta-arrestin 2 that limit self-association also interfere with interactions with the beta2-adrenoceptor and the ERK1/2 MAPKs: implications for beta2-adrenoceptor signalling via the ERK1/2 MAPKs.
Xu TR; Baillie GS; Bhari N; Houslay TM; Pitt AM; Adams DR; Kolch W; Houslay MD; Milligan G
Biochem J; 2008 Jul; 413(1):51-60. PubMed ID: 18435604
[TBL] [Abstract][Full Text] [Related]
10. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
[TBL] [Abstract][Full Text] [Related]
11. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation.
Kara E; Crépieux P; Gauthier C; Martinat N; Piketty V; Guillou F; Reiter E
Mol Endocrinol; 2006 Nov; 20(11):3014-26. PubMed ID: 16887887
[TBL] [Abstract][Full Text] [Related]
12. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
13. Distinct and shared roles of β-arrestin-1 and β-arrestin-2 on the regulation of C3a receptor signaling in human mast cells.
Vibhuti A; Gupta K; Subramanian H; Guo Q; Ali H
PLoS One; 2011 May; 6(5):e19585. PubMed ID: 21589858
[TBL] [Abstract][Full Text] [Related]
14. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5.
Bolger GB; Baillie GS; Li X; Lynch MJ; Herzyk P; Mohamed A; Mitchell LH; McCahill A; Hundsrucker C; Klussmann E; Adams DR; Houslay MD
Biochem J; 2006 Aug; 398(1):23-36. PubMed ID: 16689683
[TBL] [Abstract][Full Text] [Related]
15. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667
[TBL] [Abstract][Full Text] [Related]
16. ERK and β-arrestin interaction: a converging point of signaling pathways for multiple types of cell surface receptors.
Eishingdrelo H; Sun W; Li H; Wang L; Eishingdrelo A; Dai S; McKew JC; Zheng W
J Biomol Screen; 2015 Mar; 20(3):341-9. PubMed ID: 25361946
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species are required for β2 adrenergic receptor-β-arrestin interactions and signaling to ERK1/2.
Singh M; Moniri NH
Biochem Pharmacol; 2012 Sep; 84(5):661-9. PubMed ID: 22728070
[TBL] [Abstract][Full Text] [Related]
18. The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation.
Milasta S; Evans NA; Ormiston L; Wilson S; Lefkowitz RJ; Milligan G
Biochem J; 2005 May; 387(Pt 3):573-84. PubMed ID: 15683363
[TBL] [Abstract][Full Text] [Related]
19. Differential conformational requirements for activation of G proteins and the regulatory proteins arrestin and G protein-coupled receptor kinase in the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein.
Vilardaga JP; Frank M; Krasel C; Dees C; Nissenson RA; Lohse MJ
J Biol Chem; 2001 Sep; 276(36):33435-43. PubMed ID: 11387315
[TBL] [Abstract][Full Text] [Related]
20. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.
DeFea KA; Zalevsky J; Thoma MS; Déry O; Mullins RD; Bunnett NW
J Cell Biol; 2000 Mar; 148(6):1267-81. PubMed ID: 10725339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
